Product Information
NITROFURANTOIN MONO-MCR 100 MG is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2958 per EA under NDC 65862092901. Its NADAC has been published 117 times since Jul 10, 2024.
FDA first approved this application on Mar 30, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 75 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862092901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NITROFURANTOIN; NITROFURANTOIN MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA209225FDA Approved
3/30/2023
TE Code
AB
On Market Since
3/30/2023
Pharmacological Classes
Price Statistics
The NADAC for NITROFURANTOIN MONO-MCR 100 MG has been published 117 times since Jul 10, 2024, and over the history we have for it it has declined 43.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2958 per EA |
|---|---|
| All-time high | $0.5238 (Jul 10, 2024) |
| All-time low | $0.2561 (Nov 20, 2024) |
| 52-week high | $0.3519 |
| 52-week low | $0.2958 |
| Median price | $0.3298 |
| Average price | $0.3407 |
| Largest weekly change | -26.6% (Nov 20, 2024) |
| Weeks tracked | 117 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Nitrofurantoin (Monohydrate/Macrocrystals) market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nitrofurantoin (Monohydrate/Macrocrystals) market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitrofuran Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NITROFURANTOIN MONO-MCR 100 MG?
The current National Average Drug Acquisition Cost (NADAC) for NITROFURANTOIN MONO-MCR 100 MG, manufactured by Aurobindo Pharma Limited, is $0.2958 per EA (NDC 65862092901), effective Sep 30, 2026.
How has the price of NITROFURANTOIN MONO-MCR 100 MG changed over time?
Over the history we have for it, the NADAC for NITROFURANTOIN MONO-MCR 100 MG has declined 43.5%. It has been tracked across 117 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for NITROFURANTOIN MONO-MCR 100 MG?
Since Jul 10, 2024, the NADAC for NITROFURANTOIN MONO-MCR 100 MG has ranged from a low of $0.2561 (Nov 20, 2024) to a high of $0.5238 (Jul 10, 2024), with a median of $0.3298 per EA.
Are there cheaper alternatives to NITROFURANTOIN MONO-MCR 100 MG?
No other NADAC-published product currently shares the active ingredient and strength of NITROFURANTOIN MONO-MCR 100 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NITROFURANTOIN MONO-MCR 100 MG?
NITROFURANTOIN MONO-MCR 100 MG (NDC 65862092901) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.